Trial: 202111065

A Phase 1/2, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients with Solid Tumors Dependent on KIT or PDGFRA Signaling

Phase

I/II

Principal Investigator

Abdelbaki, Mohamed

Disease Site

Bones and Joints; Brain and Nervous System; Other Male Genital; Soft Tissue

Learn more about this study at: clinicaltrials.gov